Skip to main content
. Author manuscript; available in PMC: 2011 Nov 15.
Published in final edited form as: Biol Psychiatry. 2010 Nov 15;68(10):903–912. doi: 10.1016/j.biopsych.2010.08.025

Figure 7.

Figure 7

Plasma samples of the validation cohort (N=237) were evaluated for YKL-40 by ELISA. (A) Mean plasma YKL-40 was significantly higher in the CDR 0.5 and CDR 1 groups as compared to the CDR 0 group (+ p=.046, * p=.031; One-way ANOVA, Tukey post-hoc Test) (CDR 0= 62.5 +/− 3.4; CDR 0.5= 81.1 +/− 8.0; CDR 1= 91.9 +/− 15.0, ng/mL, mean +/− SEM). (B) CSF and plasma YKL-40 levels are significantly correlated (r =.2376, p=.0002).